NCT05047458View on ClinicalTrials.gov

A Study of Single-dose ALXN2050 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 28, 2017

Primary Completion Date

April 13, 2018

Study Completion Date

April 13, 2018

Conditions
Healthy
Interventions
DRUG

ALXN2050

Powder-in-capsule (PIC).

DRUG

Placebo

PIC.

Trial Locations (1)

Unknown

Clinical Trial Site, Auckland

Sponsors
All Listed Sponsors
collaborator

Achillion, a wholly owned subsidiary of Alexion

INDUSTRY

lead

Alexion Pharmaceuticals, Inc.

INDUSTRY